Kebebew E - Search Results

1

Zarnegar R, Kebebew E, Duh QY, Clark OH. Zarnegar R, et al. Among authors: kebebew e. Surg Oncol Clin N Am. 2006 Jul;15(3):555-71. doi: 10.1016/j.soc.2006.05.009. Surg Oncol Clin N Am. 2006. PMID: 16882497 Review.

2

Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis.

Kebebew E, Clark OH. Kebebew E, et al. Surg Oncol Clin N Am. 1998 Oct;7(4):721-48. Surg Oncol Clin N Am. 1998. PMID: 9735131 Review.

3

Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up.

Kebebew E, Duh QY. Kebebew E, et al. Surg Oncol Clin N Am. 1998 Oct;7(4):765-89. Surg Oncol Clin N Am. 1998. PMID: 9735133 Review.

4

Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature.

Kebebew E, Tresler PA, Siperstein AE, Duh QY, Clark OH. Kebebew E, et al. Thyroid. 1999 Feb;9(2):127-31. doi: 10.1089/thy.1999.9.127. Thyroid. 1999. PMID: 10090311 Review.

5

Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function.

Kebebew E, Wong MG, Siperstein AE, Duh QY, Clark OH. Kebebew E, et al. J Clin Endocrinol Metab. 1999 Aug;84(8):2840-7. doi: 10.1210/jcem.84.8.5913. J Clin Endocrinol Metab. 1999. PMID: 10443689

6

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.

Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Kebebew E, et al. Cancer. 2000 Mar 1;88(5):1139-48. doi: 10.1002/(sici)1097-0142(20000301)88:5<1139::aid-cncr26>3.0.co;2-z. Cancer. 2000. PMID: 10699905

7

Differentiated thyroid cancer: "complete" rational approach.

Kebebew E, Clark OH. Kebebew E, et al. World J Surg. 2000 Aug;24(8):942-51. doi: 10.1007/s002680010165. World J Surg. 2000. PMID: 10865038 Review.

8

Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.

Kebebew E, Kikuchi S, Duh QY, Clark OH. Kebebew E, et al. Arch Surg. 2000 Aug;135(8):895-901. doi: 10.1001/archsurg.135.8.895. Arch Surg. 2000. PMID: 10922248

9

Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model.

Kebebew E, Duh QY, Clark OH. Kebebew E, et al. World J Surg. 2000 Nov;24(11):1295-302. doi: 10.1007/s002680010215. World J Surg. 2000. PMID: 11038197

10

The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer.

Kebebew E, Treseler PA, Duh QY, Clark OH. Kebebew E, et al. Surgery. 2000 Dec;128(6):952-7. doi: 10.1067/msy.2000.111082. Surgery. 2000. PMID: 11114629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters